Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Majus Misiak, Mateusz Heldt, Marlena Szeligowska, Stefania Mazzini, Leonardo Scaglioni, Grzegorz J. Grabe, Marcin Serocki, Jan Lica, Marta Switalska, Joanna Wietrzyk, Giovanni L. Beretta, Paola Perego, Dominik Zietkowski, Maciej Baginski, Edward Borowski, Andrzej Skladanowski
Published Oct 10, 2017 · Vol. 8, No. 62 · pp. 105137-105154
Michelle A. Schultz, Andrew M. Diaz, Sharon Smite, Anna R. Lay, Brian DeCant, Ronald McKinney, Windel E. Mascarinas, Yinglin Xia, Carola Neumann, David Bentrem, David W. Dawson, Paul J. Grippo
Published Oct 4, 2017 · Vol. 8, No. 54 · pp. 92667-92681
Oscar M.J.A. Stassen, Emma J. van Bodegraven, Fabrizio Giuliani, Martina Moeton, Regina Kanski, Jacqueline A. Sluijs, Miriam E. van Strien, Willem Kamphuis, Pierre A.J. Robe, Elly M. Hol
Published Oct 4, 2017 · Vol. 8, No. 50 · pp. 88104-88121